Axon Enterprise DSO Ratio 2011-2025 | AXON

Annual DSO Ratio Axon Enterprise

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	134	126	59.5	53.7	51.1	68.2	59.6	57.6	47.8

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
134	47.8	73

Quarterly DSO Ratio Axon Enterprise

2025-Q1	2024-Q4	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21.9	47.8	25.5	-	46.4	53	33.1	-	44.1	50.7	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
53	21.9	40.3

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
AbbVie ABBV	267	$ 223.01	-0.99 %	$ 395 B	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	31.5	$ 4.68	1.85 %	$ 777 M	Canada
Aclaris Therapeutics ACRS	6.01	$ 3.38	3.21 %	$ 261 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Ascendis Pharma A/S ASND	132	$ 212.3	5.5 %	$ 5 B	Danmark
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Aptorum Group Limited APM	20.6	$ 1.33	-1.48 %	$ 7.25 M	China
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.4	1.49 %	$ 8.18 B	Australia
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	62.6	$ 25.76	0.19 %	$ 1.25 B	USA
Anika Therapeutics ANIK	77.3	$ 9.53	-1.19 %	$ 140 M	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Biogen BIIB	57.9	$ 173.03	-2.55 %	$ 25.2 B	USA
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Aytu BioScience AYTU	150	$ 2.33	2.3 %	$ 14.6 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Baudax Bio BXRX	126	-	0.59 %	$ 63 K	USA
Catalyst Biosciences CBIO	3.24	$ 15.32	5.73 %	$ 1.01 B	USA
ChromaDex Corporation CDXC	13.2	-	-0.88 %	$ 598 M	USA
Cerus Corporation CERS	59.2	$ 2.14	13.23 %	$ 395 M	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Celldex Therapeutics CLDX	86.5	$ 28.33	0.5 %	$ 1.82 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 0.29	-5.01 %	$ 631 M	Israel
Benitec Biopharma BNTC	141	$ 12.91	0.78 %	$ 531 M	USA
Cytokinetics, Incorporated CYTK	177	$ 60.38	0.11 %	$ 6.76 M	USA
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	169	$ 11.55	8.86 %	$ 747 M	USA
Dynavax Technologies Corporation DVAX	56.5	$ 10.89	-0.09 %	$ 1.42 B	USA
Eloxx Pharmaceuticals ELOX	157	-	-5.68 %	$ 8.28 M	USA